PayloopPayloop
CommunityVoicesToolsDiscoverLeaderboardReportsBlog
Save Up to 65% on AI
Powered by Payloop — LLM Cost Intelligence
Tools/Recursion vs Abridge
Recursion

Recursion

ai-healthcare
vs
Abridge

Abridge

ai-healthcare

Recursion vs Abridge — Comparison

Overview
What each tool does and who it's for

Recursion

Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us

Recursion was founded more than a decade ago on the idea that we could take images of cells and use these images to train artificial intelligence to understand the vast unknown biological space – the cellular disruptions driving disease – to use AI-drug discovery to reduce the massive 90% failure rate of traditional drug discovery. Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas Leveraging the Power of Patient Data in AI-Drug Discovery Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

Abridge

Download whitepaper

Our mission is to power deeper understanding in healthcare through purpose-built AI. “We’re giving agency back to clinicians, creating clarity for patients, and establishing radical efficiencies to transform healthcare from the conversation up.” Working at Abridge gives me the opportunity to advocate for patients the way I do at my weekly clinic, but at scale. This is the moment when AI transforms healthcare. I joined Abridge to improve clinician lives by pushing the frontiers of this technology and rolling it out responsibly. Healthcare is inherently human. Working at Abridge means I can help restore connection and meaning to every clinician-patient visit. I joined Abridge to help transform the patient-provider interaction that is fundamental to healthcare. I joined Abridge because Abridge’s DNA in healthcare and technology has enabled us to create a magical product that enhances millions of medical conversations each year. Technology is nothing without empathy. I joined Abridge because it's a rare company that marries the most cutting-edge technology with a real, palpable understanding of the biggest challenges facing healthcare. We embrace challenges and transform constraints into unique solutions. Obstacles don’t deter us—we find a way to move around them, flowing like water. We ship, learn, iterate, and empower each other to maintain momentum. We focus on reducing cycle time, working together to figure out how to do things better and faster. We work in a blameless culture, with a relentless pursuit for continuous improvement. We’re curious people and it makes sense—you have to taste good things to have good taste. As lifelong learners, we continuously seek knowledge and the ‘why’ behind the ‘what.’ We love nerding out. We leave egos behind in pursuit of achieving success as a team. Success for us is a team sport and we use constructive feedback to help each other achieve growth. We empathize with the needs of our users, accounting for their daily challenges and aspirations. We develop a deep understanding of how we can best serve them, earning and maintaining trust. Your Abridge report has been sent to your email.

Key Metrics
—
Avg Rating
—
0
Mentions (30d)
0
—
GitHub Stars
—
—
GitHub Forks
—
—
npm Downloads/wk
—
—
PyPI Downloads/mo
—
Community Sentiment
How developers feel about each tool based on mentions and reviews

Recursion

0% positive100% neutral0% negative

Abridge

0% positive100% neutral0% negative
Pricing

Recursion

tiered

Abridge

tiered
Use Cases
When to use each tool

Recursion (1)

The future of TechBio
Features

Only in Recursion (10)

The future of TechBioLEARN HOWDecoding biology to radically improve livesBetter medicines, through novel insights and precision designDelivering for our partners3 key ingredients: data, models, and computeThe latest from RecursionGet In TouchGet InvolvedPolicies

Only in Abridge (1)

Announcing Real Time Prior Authorization at the Point of Conversation
Product Screenshots

Recursion

Recursion screenshot 1

Abridge

Abridge screenshot 1Abridge screenshot 2Abridge screenshot 3Abridge screenshot 4
Company Intel
research
Industry
hospital & health care
800
Employees
330
—
Funding
$757.5M
—
Stage
Series E
Supported Languages & Categories

Recursion

AI/MLDeveloper Tools

Abridge

AI/MLDevOps
View Recursion Profile View Abridge Profile